Gyre Therapeutics, Inc. (GYRE) Financials

GYRE Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 199.3 million 34.3 million
March 31, 2026 162.0 million 25.0 million
Dec. 31, 2025 166.1 million 23.9 million
Sept. 30, 2025 159.4 million 22.0 million

GYRE Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -18.0 million 2.1 million
March 31, 2026 3.0 million 2.6 million
Dec. 31, 2025 -5.8 million 4.6 million
Sept. 30, 2025 4.0 million 1.1 million

GYRE Net Income

No data available :(

GYRE Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 74.8 million - 3.4 million
March 31, 2026 49.8 million - 823000
Dec. 31, 2025 52.4 million - 939000
Sept. 30, 2025 60.0 million - 1.2 million

GYRE Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 100.6 million
March 31, 2026 91.3 million
Dec. 31, 2025 102.9 million
Sept. 30, 2025 102.7 million

GYRE Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 1.3 million 19.1 million 21.6 million 13.8 million
March 31, 2026 178000 6.7 million 21.4 million 14.1 million
Dec. 31, 2025 144000 4.8 million 30.5 million 23.8 million
Sept. 30, 2025 683000 2.4 million 19.6 million 15.3 million

GYRE Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 29.1 million 2.2 million
March 31, 2026 22.5 million 1.2 million
Dec. 31, 2025 37.2 million 1.7 million
Sept. 30, 2025 30.6 million 1.6 million

GYRE Revenue by Segment
Graph available only for paid members. Upgrade to see it.

GYRE

Price: $7.02

52 week price:
5.44
9.42

Payout Ratio Range:
-6400.16%
11221.82%

Earnings Per Share: -0.21 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 708.3 million

Links: